Latest news
Loading news…
Oxford Phamascience
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. London, England, United Kingdom Founded 2008 1-10 employees For Profit
Oxford Pharmascience offers technology platforms to re-develop existing medicines.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
6
4 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Delisted
- Ticker
- OXP
- Exchange
- LSE - London Stock Exchange
- IPO date
- Jan 12, 2011
- Delisted
- Dec 21, 2017
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 3
- Active products
- 5
- Patents granted
- 6
- Trademarks
- 4
- Top patent class
- a61
- IT spend
- $22K
Company Info
- Founded
- 2008
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 1
- HQ
- London, England, United Kingdom
- Region
- Europe, Middle East, and Africa (EMEA)
- Exit date
- Jan 12, 2011
Signals & Scores
- Growth score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- -0.4
- Trend (90d)
- -0.4
Key People at Oxford Phamascience
CEO
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Oxford Phamascience
Loading news…
FAQs about Oxford Phamascience
People who checked this page also checked these
Browse the full Acquirezy directory.